Skip to main content
. 2020 Nov 27;12(11):897–907. doi: 10.4254/wjh.v12.i11.897

Table 1.

Summary of literature on dermatological paraneoplastic syndromes in cholangiocarcinoma

Ref.
Year
Paraneoplastic syndrome
Mediator
Dermatologic
Ravnborg et al[15] 1993 Acanthosis nigricans TGF-alpha
Suchonwanit et al[19] 2018 Alopecia T-lymphocytes
Antoniou et al[20] 2012 Alopecia T-lymphocytes
Suh et al[23] 2016 Dermatomyositis
Yasuda et al[26] 2018 Dermatomyositis
Sotoodian et al[27] 2018 Disseminated superficial porokeratosis p53
Cannavó et al[29] 2008 Disseminated superficial porokeratosis p53
Chiyomaru et al[33] 2010 Necrolytic migratory erythema
Tzovaras et al[36] 2007 Persistent erythema multiforme
Shinojima et al[39] 2006 Sweet syndrome G-CSF, IL-1, IL-6
Karabulut et al[43] 2006 Bazex syndrome
Liau et al[47] 2016 Erythema gyratum
Bar-Ilan et al[48] 2017 Pityriasis rubra pilaris
Morgenthau et al[51] 2019 Sign of leser- trelat EGF-alpha
Opneja et al[53] 2015 Subacute cutaneous lupus erythematosus

TGF-alpha: Tissue growth factor-alpha; G-CSF: Granulocyte-colony stimulating factor; IL: Interleukin; EGF-alpha: Epidermal growth factor-alpha.